Drug Regulatory Authorities in France Call For Limitations on Use of Yaz, Yasmin

May 24, 2014
by Adler Markoff & Associates

Request A Free Consultation

(405) 607-8757

    Drug Regulatory Authorities in France Call For Limitations on Use of Yaz, Yasmin

    A French drug safety agency recently indicated that newer forms of oral contraceptives, like Yaz and Yasmin, should be prescribed to patients as a “last resort,” as the drug regulators called for limitations on the use of the birth control pills due to the risk of blood clots. In fact, the national drug safety agency (ANSM) is advising doctors to only prescribe so-called third- and fourth-generation oral contraceptives (those introduced since the 1990s) if their patients are unable to take the older generation pills. If you took Yaz or Yasmin and you have experienced a serious side effect like the development of a dangerous blood clot, contact our skilled lawyers at AMA Law to discuss the possibility of filing a defective drug claim against Bayer.


    Last week, the ANSM launched an investigation into how newer birth control pills are being prescribed, concluding that the risk of blood clots and other ailments associated with the products casts doubt on the safety of the oral contraceptives. Concerns center around mounting research indicating that newer birth control pills may double the risk of blood clots in patients when compared to older products, which can lead to life-threatening medical events like stroke, pulmonary embolism and deep vein thrombosis (DVT). These potential risks have raised serious concerns in the French medical community, and, beginning on March 31, the country of France will no longer reimburse prescription costs of third-generation birth control pills.


    An estimated two million women in France use Yaz, Yasmin and other newer-generation oral contraceptives, and ANSM officials have hinted that they may recall some of the newer brands if medical professionals don’t stop prescribing them in large numbers. This recent regulatory action by ANSM comes as Bayer attempts to resolve thousands of lawsuits filed against the drug firm on behalf of patients who claim that Bayer failed to warn consumers about the potential side effects linked to Yaz and Yasmin. Bayer faces a whopping 12,000-plus claims involving its birth control pills in the United States, and has reached settlements in about 3,500 at a cost of approximately $750 million.


    Earlier this year, the Yaz and Yasmin MDL (multidistrict litigation) became the largest pending consolidated litigation in the United States, with the total number of cases surpassing even the asbestos litigation. If you have suffered from a major side effect like stroke or pulmonary embolism, and you believe Bayer’s Yaz or Yasmin oral contraceptives to be the cause, contact our reputable attorneys at AMA Law today. Our lawyers are familiar with Yaz and Yasmin litigation, and will work diligently to help you pursue the financial compensation you deserve for your injuries and medical expenses.

    Request a free consultation

    (405) 607-8757